Figure 4 KIF2A overexpression reverses the effects of PEG10 knockdown on the progression of DLBCL. (A, B) The mRNA and protein level of KIF2A in SU-DHL-8 and OCI-LY-8 cells. (C, D) Measurement of cell proliferation and apoptosis by MTT and flow cytometry, respectively. (E, F) Transwell assays used for the measurement of the migratory and invasive abilities of SU-DHL-8 and OCI-LY-8 cells. * P<0.05. KIF2A – kinesin family member 2A; DLBCL,– diffuse large B-cell lymphoma; RT-qPCR – real-time quantitative polymerase chain reaction.